SCHEMBL9004285

SCHEMBL9004285

Cc1ccc2c(c1)Oc1ccc([N+](=O)[O-])cc1C(=O)N2C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.56
CASP1 P29466 1/20 0.56
CASP4 P49662 1/20 0.56
CASP7 P55210 1/20 0.56
CASP9 P55211 1/20 0.56
CASP6 P55212 1/20 0.56
NR1H2 P55055 2/20 0.52
NR1H3 Q13133 2/20 0.52
CHRM2 P08172 1/20 0.49
HTR1A P08908 1/20 0.49
ADRA2A P08913 1/20 0.49
DRD1 P21728 1/20 0.49
PTGS1 P23219 1/20 0.49
SLC6A4 P31645 1/20 0.49
DRD3 P35462 1/20 0.49
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MAOB P27338 2/20 0.40
MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9101244 0.81 CASP1 (0.45) CASP3CASP1CASP4CASP7CASP9
SCHEMBL9004267 0.79 NR1H2 (0.47) CASP1CASP7NR1H2NR1H3CA1
SCHEMBL2113066 0.76 ALDH1A1 (0.56) CASP3ALDH1A1MAPTLMNACAPN9
SCHEMBL29214096 0.76 CASP1 (0.48) CASP3CASP1CASP4CASP7CASP9
SCHEMBL30867079 0.76 CASP1 (0.48) CASP3CASP1CASP4CASP7CASP9
SCHEMBL13402242 0.74 MAPT (0.57) CASP3CASP1CASP4CASP7CASP9
SCHEMBL13437129 0.74 MAPT (0.57) CASP3ALDH1A1MAOBMAOAMAPT
SCHEMBL9807143 0.74 ACHE (0.41) CASP3CASP1CASP4CASP7CASP9
SCHEMBL30232255 0.72 CASP3 (1.00) CASP3CASP1CASP4CASP7CASP9
SCHEMBL3594484 0.72 CASP3 (1.00) CASP3CASP1CASP4CASP7CASP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5571806-A Dibenz[b,f][1,4]oxazepin(and thiazepin)-11(10H)-ones and-thiones and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-11-05 US disclosed
EP-0419861-B1 Use of dibenz[b,f][1,4]oxazepin (and thiazepin)-11(10H)-ones and -thiones in the preparation of a pharmaceutical composition for the prevention or treatment of aids BOEHRINGER INGELHEIM PHARMA (US) 1995-11-02 EP disclosed
EP-0419861-A2 Use of dibenz[b,f][1,4]oxazepin (and thiazepin)-11(10H)-ones and -thiones in the preparation of a pharmaceutical composition for the prevention or treatment of aids BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-04-03 EP disclosed